Lih‐Ling Lin
scPharmaceuticals (United States)
ORCID: 0000-0001-7359-7686Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “The Interleukin‐1 Receptor–Associated Kinase 4 Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial”.
Weiyong Sun, Saurav De, Aiping Jiao, M Sharif, Peter T. Symanowicz +22 more
Heidi Makrinioti, Sejal Saglani, Michael K. Bowman, Lih‐Ling Lin, Carlos A. Camargo +3 more
Linlin Zhao, Yumei Zheng, Anissa Belfetmi, Tiantian Cai, Boying Xu +9 more
Gail Newton, Liguo Wu, Lih‐Ling Lin, Amy S. Miracco, Sridaran Natesan +2 more